INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $484,958 | -1.0% | 9,310 | +20.3% | 0.02% | +5.6% |
| Q2 2023 | $489,970 | +26.0% | 7,738 | +7.7% | 0.02% | +20.0% |
| Q1 2023 | $388,959 | +11.6% | 7,183 | 0.0% | 0.02% | +7.1% |
| Q4 2022 | $348,591 | +4.4% | 7,183 | 0.0% | 0.01% | -6.7% |
| Q3 2022 | $334,000 | -14.8% | 7,183 | +4.5% | 0.02% | -11.8% |
| Q2 2022 | $392,000 | +3.7% | 6,871 | +11.4% | 0.02% | +21.4% |
| Q1 2022 | $378,000 | +29.5% | 6,170 | +10.8% | 0.01% | +40.0% |
| Q4 2021 | $292,000 | +40.4% | 5,570 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $208,000 | -8.4% | 5,570 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $227,000 | +20.1% | 5,570 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $189,000 | +6.8% | 5,570 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $177,000 | +23.8% | 5,570 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $143,000 | +21.2% | 5,570 | +21.4% | 0.01% | 0.0% |
| Q2 2020 | $118,000 | +66.2% | 4,589 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $71,000 | -44.5% | 4,589 | +22.7% | 0.00% | -33.3% |
| Q4 2019 | $128,000 | +357.1% | 3,739 | 0.0% | 0.01% | +500.0% |
| Q3 2019 | $28,000 | -42.9% | 3,739 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $49,000 | +6.5% | 3,739 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $46,000 | +7.0% | 3,739 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $43,000 | -46.9% | 3,739 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $81,000 | +9.5% | 3,739 | -10.7% | 0.00% | 0.0% |
| Q2 2018 | $74,000 | -3.9% | 4,189 | +14.1% | 0.00% | 0.0% |
| Q1 2018 | $77,000 | +45.3% | 3,672 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $53,000 | -1.9% | 3,672 | +23.9% | 0.00% | -33.3% |
| Q3 2017 | $54,000 | +45.9% | 2,964 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $37,000 | -22.9% | 2,964 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $48,000 | – | 2,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |